Inventprise Inc.
Clinical trials sponsored by Inventprise Inc., explained in plain language.
-
New 25-Strain pneumonia vaccine shows promise in infant trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine (IVT PCV-25) that protects against 25 types of bacteria that cause pneumonia and other serious infections. About 421 healthy infants will receive the vaccine at 6, 10, and 14 weeks old. Researchers will check for side effects and measure how well th…
Phase: PHASE2 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 13:57 UTC
-
New vaccine could shield babies from deadly group b strep
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine (IVT GBS-06) designed to prevent Group B Streptococcus (GBS) infections, which can cause serious illness in newborns. The trial involves 600 healthy, non-pregnant women aged 18-49 in the US and South Africa. Participants receive one of three doses o…
Phase: PHASE1, PHASE2 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:39 UTC